Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sichuan Meidakang Huakang Pharmaceutical is a Chinese pharmaceutical manufacturer focused primarily on the production, research, and sale of chemical drugs. The company appears to operate mainly as a commercial-stage generics and formulations business rather than a venture-backed innovative biotech developer. Publicly available profiles describe a portfolio spanning anti-infectives, antivirals, vitamins, and multiple sterile and oral dosage forms, including lyophilized powder injections, sterile powder injections, large-volume injections, tablets, and capsules. The business traces its roots to the former Sichuan Mianzhu Pharmaceutical Factory and was later restructured from Deyang Huakang Pharmaceutical into its current form. Available evidence suggests the company is an operating mid-sized private pharma manufacturer in Mianzhu, Sichuan, with in-house production and some formulation development capability.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sichuan Meidakang Huakang Pharmaceutical.